PATENT CLAIM ANALYSIS

Application Number: 15862997
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["435", "239000"]

Abstract:
Nucleic acids encoding Parvoviral Rep proteins with a mutated nuclear localization signal (NLS) are provided. Also provided is a nucleic acid comprising a nucleotide sequence encoding a Parvoviral Rep protein with a mutated zinc finger domain and a nucleic acid comprising a nucleotide sequence encoding a Parvoviral Rep protein comprising an amino acid mutation at position 43, 57, 79, 97, 120, 179, 305, 484, 493 or 571 with reference to SEQ ID NO: 2. Nucleic acid constructs and cells, such as insect cells, comprising the nucleic acids are provided as well as a method for producing a recombinant Parvoviral virion using the nucleic acids.

Claim (Index 10):
The nucleic acid construct of  claim 9 , wherein the at least one NLS is located at amino acids 484-491, 492-494, or 506-509 of SEQ ID NO: 2.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 86.0
- Lexical Diversity: 1.79104
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13583920', '14149953', '12918460', '12670780', '13945505']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.702232955607819
- 35 USC 102 Novelty (BERT): 0.6452687468060798
- Combined Prediction Score: 0.6965365347276451
- Mean Citation Score: 565.419026
- Max Citation Score: 823.82
- Similarity Product: 553.8985600066185

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test